Key facts
- This page summarizes Commodore Capital LP's Form 3 filing for Ambrx Biopharma Inc..
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 03 Mar 2023, 15:05.
Commodore Capital LP - 23 Feb 2023 Form 3 Insider Report for Ambrx Biopharma Inc.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 23 Feb 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 03 Mar 2023, 15:05:49 UTC
- Prior SEC filing
- 23 Feb 2023
- Next SEC filing
- 22 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Kramarz, Managing Partner
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Commodore Capital LP filed Form 3 for Ambrx Biopharma Inc. on 03 Mar 2023.
Change
- Previous filing in this sequence was filed on 23 Feb 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AMAM
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 35,700,000
- Date
- 23 Feb 2023
- Ownership
- By Commodore Capital Master LP
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The ordinary shares of the Issuer, par value $0.0001 per share (the "Ordinary Shares") may be represented by American Depositary Shares ("ADSs"). Each ADS represents seven Ordinary Shares.
Footnote F2
As of February 23, 2023, the Reporting Person owns 5,100,000 ADSs, representing 35,700,000 Ordinary Shares.
Footnote F3
The securities are held directly by Commodore Capital Master LP ("Commodore Master"). Commodore Capital LP ("Commodore Capital") is the investment manager to Commodore Master. Michael Kramarz and Robert Egen Atkinson are the managing partners of Commodore Capital and exercise investment and dispositive power over the securities held by Commodore Master. Each of Commodore Capital, Dr. Kramarz and Dr. Atkinson disclaim beneficial ownership of such securities, except to the extent of their pecuniary interest therein. This report shall not be deemed an admission that Commodore Capital, Commodore Master, Dr. Kramarz and Dr. Atkinson or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.